Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jacob J Orme

Showing results (1-10 of 73) with videos related to

Pageof 8
Sort By:
Cancer Cell|August 12, 2020
Microenvironment-Mediated Resistance to Anti-Androgen TherapyJacob J Orme, Haojie Huang
Molecular Cell|March 3, 2023
Hidden tricks in MATH: Hypermorphic mutations in SPOP tumor suppressor explained by cryo-EMJacob J Orme, Georges Mer, Haojie Huang
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 23, 2024
Delaying Prostate-Specific Antigen Progression in Biochemically Recurrent Prostate Cancer: Is It Clinically Meaningful?Daniel S Childs, Jacob J Orme, Praful Ravi
Mayo Clinic Proceedings|August 15, 2018
59-Year-Old Man With Fatigue, Weight Loss, and HepatomegalyJacob J Orme, Surbhi Sidana, Wilson I Gonsalves
Nature Cancer|May 13, 2025
CHD1 status drives divergent metabolic pathways in SPOP-mutant prostate cancerJacob J Orme, Emmanuel S Antonarakis, Scott M Dehm
BMJ (Clinical Research Ed.)|July 8, 2026
Advances in systemic therapies for advanced prostate cancerDaniel S Childs, Andrew W Hahn, Praful Ravi, et al.
Nature Reviews. Urology|February 2, 2024
The yin and yang of chromosomal instability in prostate cancerMarc Carceles-Cordon, Jacob J Orme, Josep Domingo-Domenech, et al.
Clinical Nuclear Medicine|February 20, 2024
Reversibility of Bicalutamide PSMA PET-Positive Gynecomastia With Androgen Deprivation TherapyMiguel Muniz, Daniel S Childs, Jacob J Orme, et al.
Plos One|August 23, 2016
Leukocyte Beta-Catenin Expression Is Disturbed in Systemic Lupus ErythematosusJacob J Orme, Yong Du, Kamala Vanarsa, et al.
The Oncologist|May 31, 2022
Rational Second-Generation Antiandrogen Use in Prostate CancerJacob J Orme, Lance C Pagliaro, J Fernando Quevedo, et al.
Pageof 8

Showing results (1-10 of 73) with videos related to

Sort By:
Pageof 8
Cancer Cell|August 12, 2020
Microenvironment-Mediated Resistance to Anti-Androgen TherapyJacob J Orme, Haojie Huang
Molecular Cell|March 3, 2023
Hidden tricks in MATH: Hypermorphic mutations in SPOP tumor suppressor explained by cryo-EMJacob J Orme, Georges Mer, Haojie Huang
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 23, 2024
Delaying Prostate-Specific Antigen Progression in Biochemically Recurrent Prostate Cancer: Is It Clinically Meaningful?Daniel S Childs, Jacob J Orme, Praful Ravi
Mayo Clinic Proceedings|August 15, 2018
59-Year-Old Man With Fatigue, Weight Loss, and HepatomegalyJacob J Orme, Surbhi Sidana, Wilson I Gonsalves
Nature Cancer|May 13, 2025
CHD1 status drives divergent metabolic pathways in SPOP-mutant prostate cancerJacob J Orme, Emmanuel S Antonarakis, Scott M Dehm
BMJ (Clinical Research Ed.)|July 8, 2026
Advances in systemic therapies for advanced prostate cancerDaniel S Childs, Andrew W Hahn, Praful Ravi, et al.
Nature Reviews. Urology|February 2, 2024
The yin and yang of chromosomal instability in prostate cancerMarc Carceles-Cordon, Jacob J Orme, Josep Domingo-Domenech, et al.
Clinical Nuclear Medicine|February 20, 2024
Reversibility of Bicalutamide PSMA PET-Positive Gynecomastia With Androgen Deprivation TherapyMiguel Muniz, Daniel S Childs, Jacob J Orme, et al.
Plos One|August 23, 2016
Leukocyte Beta-Catenin Expression Is Disturbed in Systemic Lupus ErythematosusJacob J Orme, Yong Du, Kamala Vanarsa, et al.
The Oncologist|May 31, 2022
Rational Second-Generation Antiandrogen Use in Prostate CancerJacob J Orme, Lance C Pagliaro, J Fernando Quevedo, et al.
Pageof 8